July 30, 2026 · Form 4 insider transaction
Hansen Gwenn bought 2,858 shares of Nurix Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.